| Mediterranean diet may prevent prostate cancer
The traditional Cretan Mediterranean-style diet, based on a variety of plant foods, may help prevent prostate cancer, according to a review.
The researchers showed that dietary intake of fruits, vegetables, wholegrain cereals, nuts and legumes along with olive oil as the main source of fat may provide protection against cancer. Moreover, low intake of red meat, moderate to low intake of dairy foods, moderate to high intake of fish and moderate intake of wine, mostly consumed with meals, may be helpful in reducing the risk.
The study showed that strong adherence to the traditional Mediterranean diet was associated with reduced all cause, cardiovascular and cancer mortality, as well as decreased incidence of Parkinson's and Alzheimer's diseases.
During a Spanish study, men and women with elevated levels of cardiovascular risk factors were randomised to either of two “Mediterranean" diets, along with olive oil or nuts, or to a control low fat diet.
Major study on DiagnoCure's GCC biomarker published in Jama
The Company also has a strategic alliance with Gen-Probe (NASDAQ: GPRO) for the development and commercialization of a second-generation prostate cancer test using PCA3, DiagnoCure's proprietary molecular marker. This test is also available through laboratories in the U.S. using PCA3 analyte specific reagents (ASR) from Gen-Probe, in Europe as the CE-marked PROGENSA(TM) PCA3 in vitro assay, and in Canada. For more information, visit www.diagnocure.com. Forward-looking statements This release contains forward-looking statements that involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expected. By their very nature, forward-looking statements are based on expectations and hypotheses and also involve risks and uncertainties, known and unknown, many of which are beyond DiagnoCure's control.
RCOG Completes Successful Atlanta Community Prostate Cancer Screening
Depending on the results from this test, men may be referred for a biopsy of the prostate. The Only Source for ProstRcision:
Radiotherapy Clinics of Georgia, based in metro Atlanta, is the only source for ProstRcision. ProstRcision is a prostate cancer radiation therapy procedure that boasts an 83% overall cure rate using the absolute strictest definition of cure, the highest documented cure rate in the world for prostate cancer. Each year hundreds of patients from across the country and throughout the world travel to Georgia to seeking cure of their prostate cancer by the ProstRcision procedure. ProstRcision is also the preferred treatment method for many men because of the lower incidences of side effects, particularly incontinence and impotence, relative to other treatment procedures.
Prostate Cancer and Maitake Mushroom
Adding a mushroom extract to interferon therapy for prostate cancer significantly improves the treatment�s effectiveness, and may help reduce both its cost and side effects, according to a study published in the Journal of Hematology and Oncology. Prostate cancer is the second deadliest cancer among elderly men in the United States. Although treatments such as surgery, chemotherapy, radiation, and hormone therapy are available, their benefits aren�t always long-lasting, they can have significant side effects, and the disease can return. Another treatment option is immunotherapy with a class of drugs known as interferons. These drugs provoke the body�s immune system to respond against the cancer, and they are thought to inhibit the cancer cells� ability to grow and differentiate.
House bill incorrectly links firefighting and cancer
"We have no idea what causes cancer," Pommier said. "But we do know that one in eight women will get breast cancer and 17 out of 100 men will get prostate cancer, and we can't say what caused it. We know there are links, such as colon cancer is linked with diet, but it's an undefeatable negative argument to try to prove causation." Studies cited in the House passage of this bill used a firefighting control group, but the studies' own analyses conclude that the "suggestive epidemiologic evidence for prostate cancer" (for instance) includes exposure to pesticides and herbicides, metallic dusts, metal working fluids, polycyclic aromatic hydrocarbons (PAHs) and diesel engine emissions. Which means lawmakers could just as well be moving to also cover car mechanics, farmworkers, bus and truck drivers and the rest of us with workers' comp cancer coverage.
Prostate Biopsy Samples Show Evidence of Differential Gene
Earlier observational studies had reported that selenium, vitamin E, or both, might reduce the risk of prostate cancer. To determine whether gene expression patterns change in patients after supplement use, Jeri Kim, M.D., of the University of Texas MD Anderson Cancer Center in Houston, and colleagues enrolled 39 patients in a phase IIA trial and randomly assigned them to receive selenium, vitamin E, both supplements, or placebo for three to six weeks before prostatectomy. Researchers then isolated and studied tumor cells, stromal cells, and normal cells from biopsy samples removed from the prostatectomy specimens. The investigators found that gene expression patterns differed between the treatment groups. Expression of several molecular pathways associated with cancer were altered in the supplement groups compared with the placebo group.
Early detection key to surviving prostate cancer
Portee's brother, Wayne, is also a prostate cancer survivor. "Ramon had it first. Then I started having trouble. I didn't think it would happen to me. It did."I had surgery in April 2001. In 2003, I had 39 radiation treatments. Tell every guy you know to take a test."Take the Portees' advice and take the opportunity for free prostate screening, being offered from noon to 3 p.m. Saturday in Elks Lakeview Lodge 1132, 1080 S. Franklin St. It's sponsored by the Emanon Club and the Macon County Health Department.It's the first time the Lakeview Elks Lodge has entered the prostate screening campaign, John Wilder said. He is the club's assistant social chairman and is a three-year prostate cancer survivor.Another survivor, Jerry Smalling, a retired high school coach, said he had radical prostate surgery in 1998.
Surgery botch-up not grave, says DHB
The mistake was based on a biopsy report which indicated cancer, but tissue tests after the procedure revealed no sign of it. Now all prostate biopsies are read by two pathologists. This case is the only one on the report being investigated by the Health and Disability Commissioner. Other cases being considered by the commissioner but not included in the serious and sentinel report is that of a Marlborough mother of three. Suzanne Wadsworth's brain tumour was not detected early enough due to health board MRI waitlist changes and she has asked the commissioner to inquire into her case, as has Nelson woman Su Wyatt, who has also laid complaints with the health board. Ms Wyatt alleged Alexandra and Nelson hospital staff misdiagnosed her 77-year-old mother and withheld food and liquids from her for almost five days last year.
Promiscuity, gonorrhea are risks for prostate cancer in men: study
Although we are unable to show that gonorrhea directly causes prostate cancer, we suspect the inflammatory effect of the gonorrhea infection may trigger pre-existing cancerous cells to multiply," says lead study author Aruna Sarma, Ph.D., assistant research scientist in the Department of Urology at U-M Medical School. In the study, 65 percent of the men with prostate cancer reported having had gonorrhea, compared to 53 percent of men without prostate cancer. Men with prostate cancer were also more likely to report being diagnosed more than once with gonorrhea, a bacterial infection transmitted through sexual intercourse. The overall rate of gonorrhea is now increasing, after a steady decline for the past two decades, according to the U.S. Centers for Disease Control and Prevention (CDC).
(12/15) ASCO recommends increase in cancer research funding and
New Treatment Options for Hard-to-Treat Cancers: Lung and pancreatic cancers are among the most lethal: lung cancer is the top cancer killer in the United States, and just five percent of pancreatic cancer patients survive five years or more following diagnosis.Two studies over the past year identified ways to improve outcomes for people with both diseases - one found that the targeted therapy cetuximab (Erbitux) improves survival for advanced non-small cell lung cancer patients; another found that the chemotherapy drug gemcitabine (Gemzar) improves survival after surgery for patients with early-stage pancreatic cancer. New Cancer Drug Approvals: Identifying and expanding treatment options for people with cancer is critical to improving patient outcomes. This year, the U.S. Food and Drug Administration (FDA) approved new treatments that will have a significant impact on patient care - the targeted therapy bevacizumab (Avastin) for women with advanced breast cancer that does not express the HER2 protein (the majority of breast cancers), and bendamustine (Treanda) for people with chronic lymphocytic leukemia, a cancer with few treatment options.
|
